China National Accord Medicines Corporation Ltd. (SZSE: 000028)
Health Care · Health Care Providers & Services · CN
CN¥19.47
-1.86% today · -17.5% 1Y
China National Accord Medicines Corporation Ltd. (SZSE: 000028) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.67B and employs 39,449 people.
Over the last twelve months the share price has lost 17.5%, trading between 18.70 and 24.94.
Tweenvest scores China National Accord Medicines Corporation Ltd. across four factors: quality 77/100, value 75/100, growth 15/100, dividend 76/100. Its strongest factor is quality.
000028 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.67B
- Revenue (TTM)
- $10.73B
- P/E
- 11.10
- EPS
- 1.75
- Dividend yield
- 2.82%
- Beta (5Y)
- 0.11
- 52-week high
- CN¥24.94
- 52-week low
- CN¥18.70
- Avg volume (3M)
- —
- Shares outstanding
- 612.22M
- Employees
- 39,449
- Next earnings
- —
About China National Accord Medicines Corporation Ltd.
China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.
- ISIN
- CNE0000009N6
- Founded
- 1993
- Listed since
- Jun 8, 1993
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $396.00 | +1.51% |
| CVS Health CorporationNYSE: CVS | $118.97B | $92.77 | -0.27% |
| McKesson CorporationNYSE: MCK | $100.14B | $870.33 | +1.33% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $431.93 | +0.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $401.48 | +0.23% |
| The Cigna GroupNYSE: CI | $73.33B | $277.86 | +0.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $322.18 | +1.30% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $230.06 | +0.24% |
Figures last refreshed Aug 18, 2026.